Seasonal influenza DES specification – updated
The Influenza and Pneumococcal Immunisation Directed Enhanced Service specification has been amended and republished to provide for additional new cohorts of patients to be vaccinated in general practice. (Source: NHS Networks)
Source: NHS Networks - September 6, 2020 Category: UK Health Source Type: news
Updated flu DES offers little detail as GPs face 'one year at a time' updates on expanded campaign
GP practices will receive the same £10.06 fee per vaccination as last year under the 2020/21 flu and pneumococcal DES, as the government insisted plans for the 'biggest flu campaign ever' would go ahead despite a lack of detail in the updated specification. (Source: GP Online News)
Source: GP Online News - September 4, 2020 Category: Primary Care Tags: Contracts & funding Source Type: news
Johnson & Johnson Announces that Janssen ’s COVID-19 Investigational Vaccine Candidate Prevents Severe Clinical Disease in Pre-clinical Studies
Janssen’s lead SARS-CoV-2 investigational vaccine candidate, Ad26.COV2.S, prevented severe clinical disease in Syrian golden hamsters, upon challenge with SARS-CoV-2, the virus that causes COVID-19 in people. The data, published today in Nature Medicine, demonstrated that the Company’s investigational adenovirus serotype 26 (Ad26) vector-based vaccine elicited an immune response as demonstrated by “neutralizing antibodies” and prevented severe clinical disease – including weight loss, pneumonia and mortality – in Syrian golden hamsters upon challenge.This publication follows Johnson & Johnson’s recent ann...
Source: Johnson and Johnson - September 3, 2020 Category: Pharmaceuticals Tags: Our Company Source Type: news
Investigational COVID-19 vaccine candidate prevents severe clinical disease in animals
(Beth Israel Deaconess Medical Center) In new research published in Nature Medicine, Beth Israel Deaconess Medical Center immunologist Dan H. Barouch, MD, PhD, and colleagues demonstrated that the optimal vaccine elicited robust immune response in Syrian golden hamsters and prevented severe clinical disease -- including weight loss, pneumonia and death. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 3, 2020 Category: International Medicine & Public Health Source Type: news
In - Hospital Heart Failure Deaths Down With Routine Vaccinations
Patients with heart failure receiving flu, pneumonia vaccinations have lower in - hospital mortality (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 1, 2020 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Geriatrics, Gynecology, Infections, Internal Medicine, Nursing, Pharmacy, Pulmonology, Conference News, Source Type: news
In-Hospital Heart Failure Deaths Down With Routine Vaccinations
TUESDAY, Sept. 1, 2020 -- For patients with heart failure, influenza and pneumococcal vaccinations are associated with lower in-hospital mortality, according to a study presented at the European Society of Cardiology Congress 2020: The Digital... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 1, 2020 Category: Pharmaceuticals Source Type: news
Vaccine narrows racial disparities in pneumococcal disease
(Vanderbilt University Medical Center) In a major public health success, the introduction of pneumococcal conjugate vaccine PCV13, or Prevnar 13, in 2010 in the United States is associated with reduction in socioeconomic disparities and the near elimination of Black-white-based racial disparities for invasive pneumococcal disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 31, 2020 Category: International Medicine & Public Health Source Type: news
Flu, Pneumonia Vaccines Save Lives of Heart Failure Patients: Study
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - August 28, 2020 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Infections, Pulmonology, News, Source Type: news
Flu, Pneumonia Vaccines Save Lives of Heart Failure Patients: Study
FRIDAY, Aug. 28, 2020 -- Flu and pneumonia vaccines lead to fewer hospital deaths among heart failure patients, a new study finds. " Our study provides further impetus for annual immunizations in patients with heart failure. Despite advice to do so,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 28, 2020 Category: General Medicine Source Type: news
Flu, Pneumonia Vaccines Save Lives of Heart Failure Patients: Study
Title: Flu, Pneumonia Vaccines Save Lives of Heart Failure Patients: StudyCategory: Health NewsCreated: 8/28/2020 12:00:00 AMLast Editorial Review: 8/28/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - August 28, 2020 Category: Cardiology Source Type: news
Vaccines against respiratory infections linked with less heart failure deaths
(European Society of Cardiology) Influenza and pneumonia vaccinations are associated with fewer hospital deaths in patients with heart failure. That's the result of a study in nearly 3 million Americans released today at ESC Congress 2020. One out of five individuals will develop heart failure in their lifetime. An estimated 26 million people are affected worldwide. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 28, 2020 Category: International Medicine & Public Health Source Type: news
Exclusive: The Chinese Scientist Who Sequenced the First COVID-19 Genome Speaks Out About the Controversies Surrounding His Work
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Health - August 25, 2020 Category: Consumer Health News Authors: Charlie Campbell / Shanghai Tags: Uncategorized COVID-19 overnight Source Type: news
Exclusive: The Chinese Scientist Who Sequenced the First COVID-19 Genome Speaks Out About the Controversies Surrounding His Work
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Science - August 25, 2020 Category: Science Authors: Charlie Campbell / Shanghai Tags: Uncategorized COVID-19 overnight Source Type: news
Exclusive: The Scientist Who Sequenced the First COVID-19 Genome Speaks Out About the Controversies Surrounding His Work
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Health - August 25, 2020 Category: Consumer Health News Authors: Charlie Campbell / Shanghai Tags: Uncategorized COVID-19 overnight Source Type: news
How Convalescent Plasma Could Help Fight COVID-19
The last time most of us gave any thought to antibodies was probably in high school biology, but we’re getting a crash refresher course thanks to COVID-19. They are, after all, the key to our best defenses against SARS-CoV-2, the virus that’s caused the global pandemic. People who have been infected likely rely on antibodies to recover, and antibodies are what vaccines are designed to produce.
Or at least that’s what infectious-disease and public-health experts assume for now. Because SARS-CoV-2 is such a new virus, even the world’s best authorities aren’t yet sure what it will take to build p...
Source: TIME: Health - August 24, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
